Core-fucosylation plays a pivotal role in hepatitis B pseudo virus infection: A possible implication for HBV glycotherapy

Glycobiology

Volumn 26, Issue 11, 2016, Pages 1180-1189

  Takamatsu, Shinji ^a   Shimomura, Mayuka ^a   Kamada, Yoshihiro ^a   Maeda, Haruka ^a   Sobajima, Tomoaki ^a   Hikita, Hayato ^a   Iijima, Masumi ^b   Okamoto, Yuta ^b   Misaki, Ryo ^b   Fujiyama, Kazuhito ^b   Nagamori, Shushi ^a   Kanai, Yoshikatsu ^a   Takehara, Tetsuo ^a   Ueda, Keiji ^a   Kuroda, Shun'ichi ^b   Miyoshi, Eiji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Core fucose; Endocytosis; Glycosylation; HBV; NTCP

Indexed keywords

FUCOSYLTRANSFERASE; LECTIN; NANOCAPSULE; OLIGOSACCHARIDE; SODIUM BILE ACID COTRANSPORTER; VIRUS RECEPTOR; FUCOSE;

ARTICLE; CONFOCAL MICROSCOPY; ENDOCYTOSIS; FLOW CYTOMETRY; FUCOSYLATION; GLYCOSYLATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MASS SPECTROMETRY; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENTRY; VIRUS GENOME; VIRUS PARTICLE; WESTERN BLOTTING; CHEMISTRY; GENETICS; METABOLISM; TUMOR CELL CULTURE;

FUCOSE; GLYCOSYLATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; NANOCAPSULES; TUMOR CELLS, CULTURED;

EID: 85016240778     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cww067     Document Type: Article

References (37)

1. Arbuthnot P, Kew M. 2001. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol. 82:77-100.
2. Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hara H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, et al. 2010. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature. 467: 859-862.
3. Cummings R, Kornfeld S. 1982. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J Biol Chem. 257:11230-11234.
4. Cocquerel L, Voisset C, Dubuisson J. 2006. Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol. 87:1075-1084.
5. Dennis JW, Granovsky M, Warren CE. 1999. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta. 1473:21-34.
6. Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H, Taniguchi N. 2004. Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res. 10:1773-1779.
7. Evans MJ, von Hahn T, Tscheme DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature. 446:801-805.
8. Isaji T, Gu J, Nishiuchi R, Zhao Y, Takahashi M, Miyoshi E, Honke K, Sekiguchi K, Taniguchi N. 2004. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem. 279:19747-19754.
9. Kao JH, Chen PJ, Chen DS. 2010. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 108:21-72.
10. Kobayashi Y, Tateno H, Dohra H, Moriwaki K, Miyoshi E, Hirabayashi J, Kawagishi H. 2012. A novel core fucose-specific lectin from the mushroom Pholiota squarrosa. J Biol Chem. 287:33973-33982.
11. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 11:97-107.
12. Lee SH, Takahashi M, Honke K, Miyoshi E, Osumi D, Sakiyama H, Ekuni A, Wang X, Inoue S, Gu J, et al. 2006. Loss of core fucosylation of lowdensity lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. J Biochem. 139:391-398.
13. Lok AS. 2002. Chronic hepatitis B. N Engl J Med. 346:1682-1683.
14. Matsumura K, Higashida K, Ishida H, Hata Y, Yamamoto K, Shigeta M, Mizuno-Horikawa Y, Wang X, Miyoshi E, Gu J, et al. 2007. Carbohydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: a novel probe for core fucose. J Biol Chem. 282: 15700-15708.
15. Miyoshi E, Fujii J, Hayashi N, Ueda K, Towata T, Fusamoto H, Kamada T, Taniguchi N. 1992. Enhancement of hepatitis-B surface-antigen expression by 5-azacytidine in a hepatitis-B-virus-transfected cell line. Int J Cancer. 52:137-140.
16. Miyoshi E, Ihara Y, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. 1995. Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611. J Biol Chem. 270:28311-28315.
17. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, et al. 2014. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for speciesspecific entry into hepatocytes. Gastroenterology. 146:1070-1083.
18. Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. 2014. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. J Hepatol. 60:723-731.
19. Ochiya T, Tsurimoto T, Ueda K, Okubo K, Shiozawa M, Matsubara K. 1989. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc Natl Acad Sci USA. 86:1875-1879.
20. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, et al. 1998. Binding of hepatitis C virus to CD81. Science. 282:938-941.
21. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 457:882-886.
22. Rademacher TW, Parekh RB, Dwek RA. 1988. Glycobiology. Annu Rev Biochem. 57:785-838.
23. Rojo MA, Yato M, Ishii-Minami N, Minami E, Kaku H, Citores L, Girbes T, Shibuya N. 1997. Isolation, cDNA cloning, biological properties, and carbohydrate binding specificity of sieboldin-b, a type II ribosomeinactivating protein from the bark of Japanese elderberry (Sambucus sieboldiana). Arch Biochem Biophys. 340:185-194.
24. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21:5017-5025.
25. Stross C, Kluge S, Weissenberger K, Winands E, Haussinger D, Kubitz R. 2013. A dileucine motif is involved in plasma membrane expression and endocytosis of rat sodium taurocholate cotransporting polypeptide (Ntcp). Am J Physiol Gastrointest Liver Physiol. 305:G722-G730.
26. Takamatsu S, Inoue N, Katsumata T, Nakamura K, Fujibayashi Y, Takeuchi M. 2005. The relationship between the branch-forming glycosyltransferases and cell surface sugar chain structures. Biochemistry. 44: 6343-6349.
27. Terao N, Takamatsu S, Minehira T, Sobajima T, Nakayama K, Kamada Y, Miyoshi E. 2015. Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes. World J Gastroenterol. 21:3876-3887.
28. Towata T, Hayashi N, Katayama K, Takehara T, Miyoshi E, Kawanishi Y, Ueda K, Kasahara A, Fusamoto H, Kamada T. 1993. Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells. Gastroenterol Jpn. 28:242-248.
29. Tsukuda S, Watashi K, Iwamoto M, Suzuki R, Aizaki H, Okada M, Sugiyama M, Kojima S, Tanaka Y, Mizokami M, et al. 2015. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression. J Biol Chem. 290:5673-5684.
30. Tsurimoto T, Fujiyama A, Matsubara K. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA. 84:444-448.
31. Ueda K, Tsurimoto T, Nagahata T, Chisaka O, Matsubara K. 1989. An in vitro system for screening anti-hepatitis B virus drugs. Virology. 169:213-216.
32. Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M, et al. 2005. Dysregulation of TGFbeta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA. 102:15791-15796.
33. Wu CS, Lee TY, Chou RH, Yen CJ, Huang WC, Wu CY, Yu YL. 2014. Development of a highly sensitive glycan microarray for quantifying AFPL3 for early prediction of hepatitis B virus-related hepatocellular carcinoma. PLoS One. 9:e99959.
34. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, Van den Driessche T, Fukuda H, Kondo A, Ueda M, Seno M, et al. 2003. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol. 21:885-890.
35. Yan H, Peng B, He W, Zhong G, Qi Y, Ren B, Gao Z, Jing Z, Song M, Xu G, et al. 2013. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol. 87:7977-7991.
36. Yan H, Zhong G, Xu G, He W, Jung Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, et al. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 1:e00049.
37. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A. 1985. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem. 260:4688-4693.